UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 6
June-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1907A13


Registration ID:
220760

Page Number

934-942

Share This Article


Jetir RMS

Title

Development and Validation of an RP-HPLC Method for Simultaneous Estimation of Meropenem and Vaborbactam in Bulk and Dosage Form

Abstract

ABSTRACT A analytical method employing reverse phase high performance liquid chromatography with PDA detection was developed to assay meropenem and vaborbactam in bulk and injection dosage form. The assay of meropenem and vaborbactam was achieved by Supelco C8 column (25 cm × 4.6 mm, 5 μm particle size) with isocratic elution. The mobile phase involved is methanol and potassium dihydrogen phosphate (0.1 Molar) mixed in ratio 65/35 (v/v). The eluted meropenem and vaborbactam are monitored at wavelength 235 nm. The procedure employed separated meropenem and vaborbactam within six min run time. Retention time of meropenem and vaborbactam were found to be 2.915 and 3.406. The parameters were tested by validating system suitability, linearity, sensitivity, selectivity, accuracy, robustness and precision. Linearity of meropenem and vaborbactam was in range of concentration 500 – 1500 µg/ml. The LOD and LOQ values were found to be 0.706 and 2.352 µg/ml for meropenem and 0.453 and 1.510 µg/ml for vaborbactam. For precision, relative standard deviation were found to be 0.102% (meropenem) and 0.050% (vaborbactam). The percent recoveries were 100.20 -100.36% and 99.60-99.67% for meropenem and vaborbactam respectively. The selectivity results proved the non interference from excipients. So this method is recommended for the routine analysis of meropenem and vaborbactam in laboratories of quality control.

Key Words

Key words: Meropenem, Vaborbactam, RP-HPLC Method, Validation.

Cite This Article

"Development and Validation of an RP-HPLC Method for Simultaneous Estimation of Meropenem and Vaborbactam in Bulk and Dosage Form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 6, page no.934-942, June 2019, Available :http://www.jetir.org/papers/JETIR1907A13.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Development and Validation of an RP-HPLC Method for Simultaneous Estimation of Meropenem and Vaborbactam in Bulk and Dosage Form", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 6, page no. pp934-942, June 2019, Available at : http://www.jetir.org/papers/JETIR1907A13.pdf

Publication Details

Published Paper ID: JETIR1907A13
Registration ID: 220760
Published In: Volume 6 | Issue 6 | Year June-2019
DOI (Digital Object Identifier):
Page No: 934-942
Country: Guntur, Andhra Pradesh, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002892

Print This Page

Current Call For Paper

Jetir RMS